Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
D1/2 urostomy bag
23961209600
|
D1/2 urostomy bag | Urostomy Bags | Stoma Appliances | No data available |
|
D1/6 ileostomy appliance 25mm
23651206505
|
D1/6 ileostomy appliance 25mm | Ileostomy Sets | Stoma Appliances | No data available |
|
D1/6 ileostomy appliance 32mm
23651206506
|
D1/6 ileostomy appliance 32mm | Ileostomy Sets | Stoma Appliances | No data available |
|
D1/6 ileostomy appliance 38mm
23651206507
|
D1/6 ileostomy appliance 38mm | Ileostomy Sets | Stoma Appliances | No data available |
|
D1/6 ileostomy appliance 44mm
23651206508
|
D1/6 ileostomy appliance 44mm | Ileostomy Sets | Stoma Appliances | No data available |
|
D1/6 ileostomy bag 25mm
23601206005
|
D1/6 ileostomy bag 25mm | Ileostomy Bags | Stoma Appliances | No data available |
|
D1/6 ileostomy bag 32mm
23601206006
|
D1/6 ileostomy bag 32mm | Ileostomy Bags | Stoma Appliances | No data available |
|
D1/6 ileostomy bag 38mm
23601206007
|
D1/6 ileostomy bag 38mm | Ileostomy Bags | Stoma Appliances | No data available |
|
D1/6 ileostomy bag 44mm
23601206008
|
D1/6 ileostomy bag 44mm | Ileostomy Bags | Stoma Appliances | No data available |
|
D3 Lemon Melts 500unit tablets
0906040G0DCAADC
|
D3 Lemon melts | Colecalciferol | Nutrition and Blood | No data available |
|
D3-50 50,000unit capsules
0906040G0BLAAEQ
|
D3-50 | Colecalciferol | Nutrition and Blood | No data available |
|
Dabigatran etexilate 20mg granules sachets sugar free
0208020X0AAADAD
|
Dabigatran etexilate | Dabigatran etexilate | Cardiovascular System | No data available |
|
Dabigatran etexilate 30mg granules sachets sugar free
0208020X0AAAEAE
|
Dabigatran etexilate | Dabigatran etexilate | Cardiovascular System | No data available |
|
Dabigatran etexilate 40mg granules sachets sugar free
0208020X0AAAFAF
|
Dabigatran etexilate | Dabigatran etexilate | Cardiovascular System | No data available |
|
Dabigatran etexilate 50mg granules sachets sugar free
0208020X0AAAGAG
|
Dabigatran etexilate | Dabigatran etexilate | Cardiovascular System | No data available |
|
Dabrafenib 50mg capsules
0801050CUAAAAAA
|
Dabrafenib | Dabrafenib | Malignant Disease and Immunosuppression | No data available |
|
Dabrafenib 75mg capsules
0801050CUAAABAB
|
Dabrafenib | Dabrafenib | Malignant Disease and Immunosuppression | No data available |
|
Dacarbazine 100mg powder for solution for injection vials
0801050L0AAAAAA
|
Dacarbazine | Dacarbazine | Malignant Disease and Immunosuppression | No data available |
|
Dacarbazine 1g powder for solution for infusion vials
0801050L0AAAEAE
|
Dacarbazine | Dacarbazine | Malignant Disease and Immunosuppression | No data available |
|
Dacarbazine 200mg powder for solution for injection vials
0801050L0AAABAB
|
Dacarbazine | Dacarbazine | Malignant Disease and Immunosuppression | No data available |
|
Dacarbazine 500mg powder for solution for infusion vials
0801050L0AAADAD
|
Dacarbazine | Dacarbazine | Malignant Disease and Immunosuppression | No data available |
|
Dacarbazine 600mg powder for solution for infusion vials
0801050L0AAACAC
|
Dacarbazine | Dacarbazine | Malignant Disease and Immunosuppression | No data available |
|
Daclatasvir 30mg tablets
0503032E0AAABAB
|
Daclatasvir | Daclatasvir | Infections | No data available |
|
Daclatasvir 60mg tablets
0503032E0AAAAAA
|
Daclatasvir | Daclatasvir | Infections | No data available |
|
Daclatasvir 90mg tablets
0503032E0AAACAC
|
Daclatasvir | Daclatasvir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.